Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan
Rhea-AI Summary
Healthcare Triangle (Nasdaq: HCTI) will effect a 1-for-60 reverse stock split effective 12:01 a.m. ET on February 10, 2026, with post-split trading on Nasdaq at market open February 10, 2026, pending DTC and Nasdaq confirmations.
The split was approved by stockholders on February 2, 2026, assigns new CUSIP 42227W405, reduces outstanding shares from ~45,417,091 to ~756,952, and is intended to help the company regain compliance with Nasdaq's $1.00 minimum bid price. Stockholders of record as of January 8, 2026 will receive post-split information from transfer agent VStock Transfer.
Positive
- Positions company to pursue Nasdaq $1.00 minimum bid compliance
- Reduces outstanding shares from ~45,417,091 to ~756,952
Negative
- Company required a reverse split due to Nasdaq minimum bid noncompliance
- Share consolidation may materially reduce free float and trading liquidity
News Market Reaction
On the day this news was published, HCTI declined 28.81%, reflecting a significant negative market reaction. Argus tracked a trough of -31.9% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $943K from the company's valuation, bringing the market cap to $2M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves: some up (e.g., MGRX, BEAT) and others down (e.g., ZCMD, VSEE), suggesting today’s reverse split news is company-specific rather than a unified sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | AI JV announcement | Positive | -7.0% | JV to drive AI and digital health transformation in Saudi Arabia. |
| Jan 29 | Partnership expansion | Positive | +0.5% | Partnership with Better to expand health data platforms across EMEA. |
| Jan 28 | Conference participation | Neutral | +10.2% | Participation and presentation at Deal Flow Discovery investor conference. |
| Jan 22 | AI acquisition deal | Positive | -7.7% | Definitive agreement for Teyame AI assets with sizable revenue forecasts. |
| Dec 10 | AI acquisition advance | Positive | +11.9% | Advance agreement to acquire AI customer engagement business with strong FY2025 revenue. |
Recent strategic and AI-related announcements have often seen mixed or even negative price reactions, indicating a tendency for the stock to sell off or react inconsistently to ostensibly positive news.
Over the last few months, Healthcare Triangle has focused on AI-driven expansion and partnerships, including a joint venture targeting the $70 billion Saudi healthcare market by 2030 and agreements to acquire Teyame AI assets with forecasted incremental revenue and EBITDA. Despite these growth initiatives, price reactions have been mixed, with both sharp gains and declines. Today’s reverse split for Nasdaq bid-price compliance follows this period of volatility and dilution-sensitive activity.
Regulatory & Risk Context
An effective Form S-3/A dated 2025-11-19 registers 1,458,118 existing-holder shares for resale via inducement and advisor warrants. The company does not sell shares directly under this shelf but notes that making these shares freely tradable could pressure the stock price and dilute existing holders over time.
Market Pulse Summary
The stock dropped -28.8% in the session following this news. A negative reaction despite the structural nature of the 1-for-60 reverse split would fit concerns about dilution and prior volatility. The stock traded near its 52-week low and far below the 200-day MA, and past growth-oriented announcements sometimes saw selling. Holders may view the split and existing resellable shares under the shelf as pressure points rather than catalysts for a durable recovery.
Key Terms
reverse stock split financial
nasdaq capital market regulatory
cusip financial
par value financial
schedule 14a regulatory
u.s. securities and exchange commission regulatory
AI-generated analysis. Not financial advice.
The Company expects that the reverse stock split, which was approved by the Company's stockholders in a special meeting of Stockholders held on February 2, 2026, will increase the price per share of the Company's common stock, and is part of the Company's strategy to regain compliance with the
At the effective time of the reverse stock split, each sixty (60) shares of the Company's issued and outstanding common stock will be automatically converted into one (1) issued and outstanding share of common stock without any change in the par value of
Stockholders of record as of January 8th, 2026, will be receiving information regarding their share ownership following the reverse stock split from the Company's transfer agent, VStock Transfer, LLC. VStock Transfer can be reached at (212) 828 8436. Additional information about the reverse stock split can be found in the Company's definitive proxy statement on Schedule 14A, filed with the
About Healthcare Triangle
Healthcare Triangle, Inc. based in
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report filed with the SEC on March 31, 2025, previous filings, subsequent filings and future periodic reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Investor Contact
1-800-617-9550
ir@healthcaretriangle.com
View original content:https://www.prnewswire.com/news-releases/healthcare-triangle-inc-announces-1-for-60-reverse-stock-split-as-part-of-nasdaq-compliance-plan-302681409.html
SOURCE Healthcare Triangle, Inc.